 BOCA RATON, Fla.--BUSINESS WIRE--TherapeuticsMD, Inc. TXMD or the Company NASDAQ: TXMD, an innovative, leading womens healthcare company, today reported financial results for the second quarter ended June 30, 2021. We continue to make steady progress in line with our expectations related to ANNOVERA and IMVEXXY driving prescription growth, net margins and broader patient access. Importantly, we are seeing improved access to health care providers for our sales force and expansion of 